secwatch / observer
8-K/A filed May 5, 2026, 7:59 PM ET ticker CHRN CIK 0001549084
M&A confidence high sentiment neutral materiality 0.95

Ekso Bionics completes reverse merger with Applied Digital subsidiary; renames to ChronoScale Corp.

EKSO BIONICS HOLDINGS, INC.

item 1.01item 2.01item 2.02item 3.02item 3.03item 4.01item 5.01item 5.02item 5.03item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001493152-26-021330
form_type
8-K/A
ticker
CHRN
cik
0001549084
company_name
EKSO BIONICS HOLDINGS, INC.
filed_at
2026-05-05T23:59:59+00:00
discovered_at
2026-05-14T18:02:32.451593+00:00
generated_at
2026-05-14T23:21:16.396961+00:00
sec_items
["1.01", "2.01", "2.02", "3.02", "3.03", "4.01", "5.01", "5.02", "5.03", "9.01"]
event_type
m_and_a
sentiment
neutral
materiality_score
0.95
calibrated_materiality_score
0.95
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001493152-26-021330
json_url
https://secwatch.observer/filing/0001493152-26-021330.json
markdown_url
https://secwatch.observer/filing/0001493152-26-021330.md
text_url
https://secwatch.observer/filing/0001493152-26-021330.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/0001493152-26-021330-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1549084/000149315226021330/form8-ka.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ying Cenly Chen

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Appointed

Douglas Miller

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Appointed

William M. Clancy

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Appointed

Scott G. Davis

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Appointed

Richard Nottenburg

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Departed

Mary Ann Cloyd

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
Appointed

Ella Benson

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg
Departed

Charles Li

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
Departed

Corinna Lathan

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
Departed

Deborah Lafer Scher

Director
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher
Appointed

Wes Cummins

Chairman of the Board
CHRN · EKSO BIONICS HOLDINGS, INC.
Effective
2026-05-05
Filed
May 5, 2026, 7:59 PM ET
the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

Source-grounded claims

60237ad5dfb38cd130991ec8d83a6f4d58c166e9

EKSO BIONICS HOLDINGS, INC. dismissed WithumSmith+Brown, PC as its auditor.

On May 5, 2026, the audit committee of the Board approved (i) the termination of the engagement of WithumSmith+Brown, PC

SEC 8-K Item 4.01/4.02 confidence 0.9 SEC evidence

b8d85d177cb7e820c51af5bbda0eb81920f5a0c5

EKSO BIONICS HOLDINGS, INC. engaged CBIZ CPAs P.C. as its auditor.

ay 5, 2026, the audit committee of the Board approved (i) the termination of the engagement of WithumSmith+Brown, PC (“Withum”), the Company’s independent registered public accounting firm prior to the Business Combination, and (ii) the engagement of CBIZ

SEC 8-K Item 4.01/4.02 confidence 0.9 SEC evidence

086f8cb203

Ying Cenly Chen was appointed as Director at EKSO BIONICS HOLDINGS, INC..

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

0ee9dfcd15

Douglas Miller was appointed as Director at EKSO BIONICS HOLDINGS, INC..

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

22e90ad815

William M. Clancy was appointed as Director at EKSO BIONICS HOLDINGS, INC..

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

34350002f6

Scott G. Davis was appointed as Director at EKSO BIONICS HOLDINGS, INC..

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

38be120717

Richard Nottenburg was appointed as Director at EKSO BIONICS HOLDINGS, INC..

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

645f2c193f

Mary Ann Cloyd resigned as Director at EKSO BIONICS HOLDINGS, INC..

the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

6d9252b185

Ella Benson was appointed as Director at EKSO BIONICS HOLDINGS, INC..

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

7612809ae5

Charles Li resigned as Director at EKSO BIONICS HOLDINGS, INC..

the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

781143cc0b

Corinna Lathan resigned as Director at EKSO BIONICS HOLDINGS, INC..

the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

a705d750bb

Deborah Lafer Scher resigned as Director at EKSO BIONICS HOLDINGS, INC..

the following directors tendered their resignations from the Board and each committee of the Board on which each such director respectively served: Mary Ann Cloyd, Corinna Lathan, Ph.D., Charles Li, Ph.D., and Deborah Lafer Scher

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

cbdef21e92

Wes Cummins was appointed as Chairman of the Board at EKSO BIONICS HOLDINGS, INC..

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

15ab66376a3871ceae050ad250c5c9041ba42ca7

EKSO BIONICS HOLDINGS, INC.: Second Amended and Restated Articles of Incorporation filed with Nevada Secretary of State, effective May 5, 2026, including name change to ChronoScale Corporation, increase in authorized common shares from 141,428,571 to 290,000,000, and other changes (effective 2026-05-05).

on May 1, 2026, the Company filed the Second Amended and Restated Articles of Incorporation (the “A&R Articles”) with the Secretary of State of the State of Nevada with a delayed effective date and time of 3:00 a.m. (Eastern Time) on May 5, 2026.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

4ee61d6d862970aeca7c200bbf8fbe29c4d24858

EKSO BIONICS HOLDINGS, INC.: Changed fiscal year end from December 31 to May 31.

In connection with the Business Combination, as of the Closing Date, the Company changed its fiscal year end from December 31 to May 31.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

f0ec14f6d93210a1db505ebcb0e7f84be8987559

EKSO BIONICS HOLDINGS, INC.: Second Amended and Restated Bylaws adopted effective upon Closing on May 5, 2026 (effective 2026-05-05).

Upon Closing and effective upon Closing, the Company adopted the Second Amended and Restated Bylaws (the “A&R Bylaws” and, together with the A&R Articles, the “Amended Charter Documents”).

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

4249547e4d2bc4a30df87d42f6dba35cef8fb35e

EKSO BIONICS HOLDINGS, INC. underwent a change of control involving Applied Digital Corporation (closed 2026-05-05).

On May 5, 2026 (the “Closing Date”), Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), consummated the previously announced business combination transaction (the “Business Combination”) contemplated by that certain Contribution and Exchange Agreement

SEC 8-K Item 2.01/5.01 confidence 0.9 SEC evidence

Comparable filings

OCFC

OceanFirst closes acquisition of Flushing Financial; issues shares to Warburg Pincus

OCEANFIRST FINANCIAL CORP June 1, 2026, 5:19 PM ET m_and_a Items 1.01, 3.02, 2.01, 2.03, 3.03, 5.02, 5.03, 7.01, 9.01

same fact type: executive_change, ma_transaction same SEC item: 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

Comparable filing

Todd Schell, designated by Warburg, was appointed to serve as a director of OceanFirst

Filing page SEC filing

Enviri II Corp

New Enviri completes spin-off; starts trading June 2 under NVRI; ~$1.2B revenue, ~$140M EBITDA

Enviri II Corp June 1, 2026, 5:18 PM ET m_and_a Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 7.01, 9.01

same fact type: governance_change, ma_transaction same SEC item: 1.01, 3.03, 5.01, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

on May 1, 2026, the Company filed the Second Amended and Restated Articles of Incorporation (the “A&R Articles”) with the Secretary of State of the State of Nevada with a delayed effective date and time of 3:00 a.m. (Eastern Time) on May 5, 2026.

Comparable filing

In connection with the Spin-Off, the Board adopted the Code of Conduct, a copy of which is available on New Enviri’s website at www.enviri.com.

Filing page SEC filing

FFIC

OceanFirst completes acquisition of Flushing Financial; FFIC holders receive 0.85 OCFC shares

FLUSHING FINANCIAL CORP June 1, 2026, 5:21 PM ET m_and_a Items 2.01, 3.01, 3.03, 5.01, 5.02, 9.01

same fact type: ma_transaction same SEC item: 2.01, 3.03, 5.01, 5.02, 9.01 same event type: m_and_a similar materiality

This filing

On May 5, 2026 (the “Closing Date”), Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), consummated the previously announced business combination transaction (the “Business Combination”) contemplated by that certain Contribution and Exchange Agreement

Comparable filing

of Flushing (“ Flushing Common Stock ”) issued and outstanding immediately prior to the Effective Time, subject to certain exceptions, was converted into the right to receive 0.85 of a share (the “ Exchange Ratio ”) of common stock, par value $0.01 per share, of OceanFirst (“ OceanFirst Common Stock ” and such consideration, the “ Merger Consideration ”).

Filing page SEC filing

CVGW

Calavo completes acquisition by Mission Produce; shareholders receive 0.9790 Mission shares + $14.85 cash per share

CALAVO GROWERS INC May 29, 2026, 6:01 AM ET m_and_a Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 9.01

same fact type: executive_change same SEC item: 2.01, 3.03, 5.01, 5.02, 9.01 same event type: m_and_a similar materiality

This filing

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

Comparable filing

B. John Lindeman, Farha Aslam, Marc L. Brown, Michael DiGregorio, Steven Hollister, Kathleen M. Holmgren, J. Link Leavens, and Adriana Mendizabal tendered their resignations as members of the board of directors of Calavo and from all committees of the board on which they formerly served, effective as of the First Effective Time.

Filing page SEC filing

NVRI

Enviri completes sale of Clean Earth to Veolia for $3.04B; spins off remaining businesses as New Enviri

ENVIRI Corp June 1, 2026, 5:15 PM ET m_and_a Items 1.02, 2.01, 3.01, 3.03, 5.01, 9.01

same fact type: ma_transaction same SEC item: 2.01, 3.03, 5.01, 9.01 same event type: m_and_a similar materiality

This filing

On May 5, 2026 (the “Closing Date”), Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), consummated the previously announced business combination transaction (the “Business Combination”) contemplated by that certain Contribution and Exchange Agreement

Comparable filing

On June 1, 2026, pursuant to the terms of the Separation Agreement and the Merger Agreement, the following series of transactions occurred

Filing page SEC filing

CECO

CECO Environmental completes acquisition of Thermon Group Holdings, issues ~22.5M shares and pays $329.4M cash

CECO ENVIRONMENTAL CORP June 1, 2026, 9:16 AM ET m_and_a Items 2.01, 2.03, 5.02, 5.03, 7.01, 9.01

same fact type: executive_change same SEC item: 2.01, 5.02, 5.03, 9.01 same event type: m_and_a similar materiality

This filing

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

Comparable filing

the Board appointed Todd Gleason, CECO’s Chief Executive Officer and an existing member of the Board, to serve as Chairman of the Board, effective as of the effective time of the First Merger.

Filing page SEC filing

FDX

FedEx completes spin-off of FedEx Freight; 80.1% distributed to FDX stockholders

FEDEX CORP June 1, 2026, 6:42 AM ET m_and_a Items 1.01, 2.01, 5.02, 8.01, 9.01

same fact type: executive_change same SEC item: 1.01, 2.01, 5.02, 9.01 same event type: m_and_a similar materiality

This filing

the Board was reconstituted as follows: Wes Cummins (Chairman), Ella Benson, Ying Cenly Chen, the Company's Chief Executive Officer, William M. Clancy, Scott G. Davis, Douglas Miller and Richard Nottenburg

Comparable filing

John A. Smith resigned from his position as Chief Operating Officer, United States and Canada of FedEx, effective as of immediately prior to the Effective Time to become the President and Chief Executive Officer of FedEx Freight.

Filing page SEC filing

RPAY

REPAY closes $372M acquisition of KUBRA, funded with new $500M term loan

Repay Holdings Corp June 1, 2026, 4:14 PM ET m_and_a Items 1.01, 2.01, 1.02, 9.01, 2.03, 7.01

same fact type: ma_transaction same SEC item: 1.01, 2.01, 9.01 same event type: m_and_a similar materiality

This filing

On May 5, 2026 (the “Closing Date”), Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), consummated the previously announced business combination transaction (the “Business Combination”) contemplated by that certain Contribution and Exchange Agreement

Comparable filing

KUBRA became an indirect wholly owned subsidiary of the Company. Pursuant to the Purchase Agreement, the aggregate cash purchase price for the Acquisition was approximately $372 million, subject to customary post-closing adjustments. The closing cash consideration was funded with a combination of cash on hand and borrowings under the Credit Agreement described

Filing page SEC filing

Source: SEC EDGAR
accession 0001493152-26-021330
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.